[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Beaura for Para Pharmaceutical Products Trading LLC\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100647471","early-phase-1-evaluation-of-the-feasibility-and-safety-of-encer-for-cancer-treatment-related-fatigue-in-patients-receiving-chemotherapy-or-radiotherapy-100647471",false,"NCT07707648","Evaluation of the Feasibility and Safety of ENCER for Cancer Treatment-Related Fatigue in Patients Receiving Chemotherapy or Radiotherapy","A Feasibility, Double Blind, Placebo-controlled Clinical Study Designed to Evaluate the Effect of 'Encer' on Cancer Treatment Related Fatigue","CTRF","Inclusion Criteria:\n\n1. Subject's informed consent\n2. Either male or female\n3. Age 18 and above\n4. Diagnosed with cancer (any type of solid tumor)\n5. Patients planned for their initial treatment or a new regimen of chemotherapy, (at least 4 treatments planned within 12 weeks) a new regimen of radiotherapy (at least 15 fractions planned)\n6. Able to interface with digital questionnaire sent to the patient electronically\n7. Willing to wear a smartwatch that will detect physiological measurements for the duration of the trial\n8. Not currently treated with homeopathic remedy (for at least one week prior to study treatment)\n\nExclusion Criteria:\n\n1. Unable to give informed consent\n2. Planned Radiotherapy for less than 15 fractions\n3. Chemotherapy anticipated for less than 12 weeks, or fewer than 4 treatments\n4. Life expectancy of less than 3 months\n5. Patient is a dependent of the sponsor, of the investigational team or his\u002Fher immediate family\n6. Pregnant or nursing women","ALL","18 Years",{"count":20,"type":21},74,"ESTIMATED","INTERVENTIONAL",[24],"EARLY_PHASE1","This is a feasibility, double blind, placebo-controlled clinical study designed to evaluate the effect of 'Encer' on Cancer treatment Related Fatigue.\n\n'Encer' is a combination of 5 Homeopathic Medical Product (HMP). The five HMPs are registered in the Homeopathic Pharmacopeia of the United States and the current investigational treatment 'Encer' is authorized for over-the-counter sales in the USA by NDC number.\n\nThe study aims to test the efficacy of 'Encer' in treating Cancer Treatment-Related Fatigue (CTRF) among cancer patients treated with chemotherapy and or radiotherapy using the Physiological measurements using Garmin vivosmart 5 and the Functional Assessment of Chronic Illness Therapy -Fatigue (FACIT-F).\n\nThis feasibility study will include patients that will be randomly assigned to either Placebo or Treatment in 1:1 ratio.",[27],"Fatigue Related to Cancer Treatment",[29,30],"cancer treatment related fatigue","homeopathy medicine for fatigue related to cancer treatments","RECRUITING","2026-07-12",{"date":34,"type":35},"2026-07-16","ACTUAL",{"date":37,"type":35},"2025-10-01",{"date":39,"type":21},"2026-10",{"name":41,"class":42},"Beaura for Para Pharmaceutical Products Trading LLC","OTHER",""]